These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 10426058)

  • 1. Drug therapy for osteoporosis management in nursing home residents.
    Lee VK; McCarthy MW
    Lippincotts Prim Care Pract; 1999; 3(2):150-62. PubMed ID: 10426058
    [No Abstract]   [Full Text] [Related]  

  • 2. ERT, HRT, raloxifine, calcitonin, or bisphosphonates for osteoporosis.
    Curtiss FR
    J Manag Care Pharm; 2003; 9(2):178-81. PubMed ID: 14613350
    [No Abstract]   [Full Text] [Related]  

  • 3. Compliance with drug therapies for the treatment and prevention of osteoporosis.
    McCombs JS; Thiebaud P; McLaughlin-Miley C; Shi J
    Maturitas; 2004 Jul; 48(3):271-87. PubMed ID: 15207894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Osteoporosis treatment in Portugal: trends and geographical variation].
    Rocha O; Lunet N; Costa L; Barros H
    Acta Med Port; 2006; 19(5):373-80. PubMed ID: 17376323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoporosis in long term care. Part 2 of 2: treatment strategies.
    Gloth FM
    Director; 2004; 12(4):234, 237-41. PubMed ID: 15540836
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacotherapeutic management of osteoprosis and osteopenia.
    Alexander IM
    Nurse Pract; 2009 Jun; 34(6):30-40; quiz 41. PubMed ID: 19474629
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of osteoporosis].
    Lakatos P
    Orv Hetil; 2003 Aug; 144(31):1551-2. PubMed ID: 14502870
    [No Abstract]   [Full Text] [Related]  

  • 8. Osteoporosis management.
    Rozenberg S; Vandromme J; Ayata NB; Filippidis M; Kroll M
    Int J Fertil Womens Med; 1999; 44(5):241-9. PubMed ID: 10569453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [From effective to economical. The value of good osteoporosis therapy].
    Minne HW; Pfeifer M; Pollähne W
    MMW Fortschr Med; 2002 May; 144(21):30-3. PubMed ID: 12134421
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacologic therapy for the treatment and prevention of osteoporosis.
    McClung B; McClung M
    Nurs Clin North Am; 2001 Sep; 36(3):433-40, viii. PubMed ID: 11532658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Quality of life before and after medical treatments in osteoporosis patients].
    Yoh K
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():625-32. PubMed ID: 15035202
    [No Abstract]   [Full Text] [Related]  

  • 12. Differing patterns of antiresorptive pharmacotherapy in nursing facility residents and community dwellers.
    Jachna CM; Shireman TI; Whittle J; Ellerbeck EF; Rigler SK
    J Am Geriatr Soc; 2005 Aug; 53(8):1275-81. PubMed ID: 16078951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy for osteoporosis.
    Gray K
    J S C Med Assoc; 2001 Mar; 97(3):114-6. PubMed ID: 11285883
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evaluation of the cost of non-hormonal treatment of osteoporosis].
    Peretz A
    Rev Med Brux; 1998 Sep; 19(4):A204-7. PubMed ID: 9805945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Drugs prescription for osteoporosis].
    Erviti J
    An Sist Sanit Navar; 2003; 26 Suppl 3():107-21. PubMed ID: 14716363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Counseling patients who elect to discontinue hormone therapy.
    Simon JA; Mack CJ
    Int J Fertil Womens Med; 2003; 48(3):111-6; discussion 137-8. PubMed ID: 12839141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Raloxifene: a new molecule for the prevention of menopausal osteoporosis].
    Oliaro A
    Minerva Ginecol; 1998 Mar; 50(3):XII-XIII. PubMed ID: 9595915
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanisms of action of antiresorptive therapies of postmenopausal osteoporosis.
    Stepan JJ; Alenfeld F; Boivin G; Feyen JH; Lakatos P
    Endocr Regul; 2003 Dec; 37(4):225-38. PubMed ID: 15106819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The search for good compliance: economic aspects of a conveyed combination pharmaco-therapy, exemplified by an osteoporosis therapy.
    Oberender P; Zerth J
    Eur J Health Econ; 2008 May; 9(2):127-36. PubMed ID: 17447094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Raloxifene: a selective estrogen receptor modulator.
    Scott JA; Da Camara CC; Early JE
    Am Fam Physician; 1999 Sep; 60(4):1131-9. PubMed ID: 10507743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.